Position in NKTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$324,975
+$92,867 QoQ
Shares Held
114,833
+4.4% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. NKTX ranks #275 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $324,975 | 114,833 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $232,108 | 110,004 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $203,559 | 110,033 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $265,044 | 128,041 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $203,903 | 122,834 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $239,774 | 130,313 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $324,873 | 130,472 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $589,728 | 130,471 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,017,475 | 172,162 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,032,894 | 95,550 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $699,414 | 105,972 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $148,820 | 107,065 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $234,681 | 107,161 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $371,357 | 104,608 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $631,770 | 105,471 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,384,970 | 105,241 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,663,285 | 135,007 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $615,713 | 54,105 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $838,232 | 54,608 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,508,330 | 54,237 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,646,167 | 51,946 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,137,972 | 64,984 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,717,274 | 60,473 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,425,294 | 47,415 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||